{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:12:30Z","timestamp":1789593150997,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA222490"],"award-info":[{"award-number":["R01CA222490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R50CA243787"],"award-info":[{"award-number":["R50CA243787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA108459\u201315"],"award-info":[{"award-number":["T32 CA108459\u201315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.apsb.2023.10.010","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T15:31:13Z","timestamp":1697902273000},"page":"292-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma"],"prefix":"10.1016","volume":"14","author":[{"given":"Tahereh","family":"Setayesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-2548","authenticated-orcid":false,"given":"Farzam","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongguang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jui","family":"Yvonne Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2023.10.010_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2023.10.010_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.livres.2020.11.006","article-title":"Hepatocellular carcinoma diagnosis and treatment: an overview","volume":"4","author":"Colquhoun","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.apsb.2023.10.010_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2023.10.010_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/378736a0","article-title":"Apoptosis of T cells mediated by galectin-1","volume":"378","author":"Perillo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2023.10.010_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.livres.2020.11.001","article-title":"Overexpression of galectin-1 and galectin-3 in hepatocellular carcinoma","volume":"4","author":"Setayesh","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.apsb.2023.10.010_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning 'sweet' on immunity: galectin\u2013glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2023.10.010_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2011.09.011","article-title":"Galectin-1 research in T cell immunity: past, present and future","volume":"142","author":"Cedeno-Laurent","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.apsb.2023.10.010_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2023.10.010_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2119\/molmed.2009.00119","article-title":"Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness","volume":"16","author":"Spano","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.apsb.2023.10.010_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6602493","article-title":"Galectin-1 as a potential cancer target","volume":"92","author":"Rabinovich","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2023.10.010_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102950118","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells","volume":"118","author":"Cagnoni","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2023.10.010_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s13046-019-1402-x","article-title":"Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells","volume":"38","author":"Leung","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2023.10.010_bib13","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jcp.24865","article-title":"Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells","volume":"230","author":"Bacigalupo","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2023.10.010_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-016-0449-1","article-title":"Galectin-1 from cancer-associated fibroblasts induces epithelial\u2013mesenchymal transition through \u03b21 integrin-mediated upregulation of Gli1 in gastric cancer","volume":"35","author":"Chong","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2023.10.010_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s13277-015-3942-9","article-title":"Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression","volume":"37","author":"Tang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.apsb.2023.10.010_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2023.10.010_bib17","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1096\/fj.201900017R","article-title":"Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model","volume":"33","author":"Potikha","year":"2019","journal-title":"Faseb J"},{"key":"10.1016\/j.apsb.2023.10.010_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2019.02.001","article-title":"The role of gut microbiota in liver disease development and treatment","volume":"3","author":"Wang","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.apsb.2023.10.010_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jnutbio.2018.04.007","article-title":"Synbiotics bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models","volume":"57","author":"Jena","year":"2018","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.apsb.2023.10.010_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41417-021-00413-6","article-title":"Safety of adeno-associated virus-based vector-mediated gene therapy\u2014impact of vector dose","volume":"29","author":"Maurya","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.apsb.2023.10.010_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"Ho","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2023.10.010_bib22","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.ajpath.2014.08.002","article-title":"Accelerated partial hepatectomy-induced liver cell proliferation is associated with liver injury in Nur77 knockout mice","volume":"184","author":"Hu","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2023.10.010_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4143\/crt.2014.321","article-title":"The prognostic role of mitotic index in hepatocellular carcinoma patients after curative hepatectomy","volume":"48","author":"Ha","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.apsb.2023.10.010_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.ymthe.2023.04.019","article-title":"miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism","volume":"31","author":"Hu","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2023.10.010_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.107.132258","article-title":"Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury","volume":"324","author":"Gyamfi","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2023.10.010_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/bioinformatics\/btab711","article-title":"ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction","volume":"38","author":"Miao","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2023.10.010_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2023.10.010_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.21037\/atm-20-2229","article-title":"Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy","volume":"9","author":"Chai","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.apsb.2023.10.010_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-61779-860-3_5","article-title":"Detection of apoptosis by TUNEL assay","volume":"887","author":"Kyrylkova","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2023.10.010_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2023.10.010_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2023.10.010_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrm2838","article-title":"The mechanism of eukaryotic translation initiation and principles of its regulation","volume":"11","author":"Jackson","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2023.10.010_bib33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","article-title":"The scanning mechanism of eukaryotic translation initiation","volume":"83","author":"Hinnebusch","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2023.10.010_bib34","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/hep.30528","article-title":"An efficient combination immunotherapy for primary liver cancer by harmonized activation of innate and adaptive immunity in mice","volume":"69","author":"Wen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2023.10.010_bib35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41417-021-00413-6","article-title":"Safety of adeno-associated virus-based vector-mediated gene therapy\u2014impact of vector dose","volume":"29","author":"Maurya","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.apsb.2023.10.010_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fgene.2019.00868","article-title":"Development and clinical translation of approved gene therapy products for genetic disorders","volume":"10","author":"Shahryari","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.apsb.2023.10.010_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ppul.24203","article-title":"Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy","volume":"54","author":"Al-Zaidy","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.apsb.2023.10.010_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-61779-370-7_6","article-title":"AAV-mediated liver-directed gene therapy","volume":"807","author":"Sands","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2023.10.010_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2023.10.010_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2018.01.009","article-title":"CD45 in human physiology and clinical medicine","volume":"196","author":"Rheinl\u00e4nder","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.apsb.2023.10.010_bib41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri2852","article-title":"The impact of the extracellular matrix on inflammation","volume":"10","author":"Sorokin","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2023.10.010_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2023.10.010_bib43","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1038\/s41388-022-02309-7","article-title":"Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts","volume":"41","author":"Tsai","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2023.10.010_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1873-3468.14047","article-title":"Galectin-1\u2013RNA interaction map reveals potential regulatory roles in angiogenesis","volume":"595","author":"Wei","year":"2021","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2023.10.010_bib45","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1200\/JCO.2005.02.0206","article-title":"Galectin-1: a link between tumor hypoxia and tumor immune privilege","volume":"23","author":"Le","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2023.10.010_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-019-0968-4","article-title":"mRNA-to-protein translation in hypoxia","volume":"18","author":"Chee","year":"2019","journal-title":"Mol Cancer"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383523004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:01:35Z","timestamp":1720594895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383523004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2211383523004045"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2023.10.010","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2023.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}